Brainmarc is a healthcare startup headquartered in Israel, with a mission to redefine brain health. Founded in 2013, the company is focused on leveraging its proprietary bei (brain engagement index) technology to develop a brain health platform targeting the aging population. Brainmarc's bei-derived therapy platform has been clinically proven to address a range of cognitive deficiency conditions, including Post Stork, TBI (Traumatic Brain Injury), and MCI (Mild Cognitive Impairment), with a commitment to improving clinical outcomes both in clinical settings and at home. The company received a €71.43K grant investment on 01 January 2019 from EASME - EU Executive Agency for SMEs.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | €71.43K | 1 | EASME - EU Executive Agency for SMEs | 01 Jan 2019 |
| Venture Round | Unknown | 1 |
|
10 Mar 2015 |
No recent news or press coverage available for brainmarc.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
